drugset
drugset / Trial / NCT06449365

Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy

NCT06449365 ↗

Phase 4 Completed 35 enrolled University of Tennessee Graduate School of Medicine
RandomizedParallel-groupOpen-labelOther

Summary

Purpose: This study compared administration of midazolam via intravenous route with nasal atomizer route for moderate sedation in an office-based vasectomy clinic.

Timeline

Start
2017-10-22
Primary completion
2020-08-07
Completion
2020-08-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midazolam Small molecule — Intravenous

Indications

No indication recorded.